Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients

This study has been completed.
Sponsor:
Information provided by:
Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT01021046
First received: November 25, 2009
Last updated: August 2, 2010
Last verified: November 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):